This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Feb;36(2):e10-2.

doi: 10.1097/IAE.0000000000000918.

Reply

James A Eadie¹, Michael S Ip

Affiliations

PMID: 26696314
DOI: 10.1097/IAE.0000000000000918

Comment

Reply

James A Eadie et al. Retina. 2016 Feb.

. 2016 Feb;36(2):e10-2.

doi: 10.1097/IAE.0000000000000918.

Authors

James A Eadie¹, Michael S Ip

Affiliation

¹ Department of Ophthalmology and Visual Science, University of Wisconsin, Madison, Wisconsin.

PMID: 26696314
DOI: 10.1097/IAE.0000000000000918

No abstract available

PubMed Disclaimer

Comment on

Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.
Eadie JA, Ip MS, Kulkarni AD. Eadie JA, et al. Retina. 2014 Dec;34(12):2439-43. doi: 10.1097/IAE.0000000000000238. Retina. 2014. PMID: 24999721
Correspondence.
Călugăru D, Călugăru M. Călugăru D, et al. Retina. 2016 Feb;36(2):e9-e10. doi: 10.1097/IAE.0000000000000917. Retina. 2016. PMID: 26655619 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations